Department of Anatomy, Laboratory of Cell Biology and Functional Anatomy (LBCAF), Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.
Life Sci. 2012 Aug 21;91(3-4):137-42. doi: 10.1016/j.lfs.2012.06.023. Epub 2012 Jul 3.
To investigate the role of TH (thyroid hormones) in 5'-nucleotidase activity and expression in cardiac soluble fraction (SF).
Male Wistar rats received daily injections of T4 (10, 25 or 50 μg T4/100g body weight) for 14 days to develop a hyperthyroidism condition. Thyroidectomy was performed in other animals to mimic hypothyroidism, and 14 days after surgery they were submitted to TH replacement therapy.
T4 reduced the 5'-nucleotidase activity (T4-25, P<0.05 and T4-50, P<0.01) in the SF. Conversely, hypothyroidism significantly increased the 5'-nucleotidase activity in this fraction (P<0.001) and TH replacement therapy reversed the latter result (P<0.001 compared to hypothyroid group). The analysis of protein expression in the SF showed that 5'-nucleotidase was more expressed in hypothyroid than in the control group and that the phosphorylated state of PKC observed in this condition may contribute to a possible mechanism of 5'-nucleotidase modulation by thyroid status.
Taken together, these data reveal that TH can influence adenosine production by modulating 5'-nucleotidase activity and expression, which may contribute to the cardioprotective effect and the maintenance of cardiac function under TH privation.
研究甲状腺激素(TH)在心脏可溶性部分(SF)中 5'-核苷酸酶活性和表达中的作用。
雄性 Wistar 大鼠每天接受 T4(10、25 或 50μg T4/100g 体重)注射,持续 14 天以建立甲状腺功能亢进状态。在其他动物中进行甲状腺切除术以模拟甲状腺功能减退,手术后 14 天,它们接受 TH 替代治疗。
T4 降低了 SF 中的 5'-核苷酸酶活性(T4-25,P<0.05 和 T4-50,P<0.01)。相反,甲状腺功能减退症显著增加了该部分的 5'-核苷酸酶活性(P<0.001),而 TH 替代治疗逆转了后者的结果(与甲状腺功能减退组相比,P<0.001)。SF 中蛋白表达的分析表明,5'-核苷酸酶在甲状腺功能减退组中的表达高于对照组,并且在这种情况下观察到的 PKC 磷酸化状态可能有助于甲状腺状态对 5'-核苷酸酶调节的可能机制。
综上所述,这些数据表明,TH 可以通过调节 5'-核苷酸酶活性和表达来影响腺苷的产生,这可能有助于 TH 剥夺下的心脏保护作用和心脏功能的维持。